Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SEC22A Inhibitors

Chemical inhibitors of SEC22A can exert their inhibitory effects through various mechanisms, targeting different aspects of the cellular machinery that SEC22A relies on for its function. Brefeldin A, for instance, disrupts Golgi apparatus structure by inhibiting ADP-ribosylation factor, a critical component for vesicle formation, thereby preventing SEC22A from participating in vesicle transport. Similarly, Exo1 inhibits the Exocyst complex, which is responsible for vesicle tethering and exocytosis, processes that involve SEC22A. Nocodazole's role in inhibiting microtubule polymerization impedes the movement of vesicles along cytoskeletal tracks, hampering SEC22A's vesicular transport functions. Also targeting the Golgi apparatus, Monensin alters the ion gradients essential for vesicle formation and secretion, which leads to an inhibition of SEC22A's trafficking role.

Continuing with this theme, Dynasore interferes with vesicle scission from the Golgi by inhibiting dynamin, thus blocking the transport pathways that involve SEC22A. Cytochalasin D contributes to the inhibition by disrupting actin polymerization, a key component of cytoskeletal integrity that SEC22A utilizes for vesicular movement. Golgicide A's inhibition of the Golgi BFA resistance factor 1 disrupts ARF function, leading to compromised vesicle trafficking and thereby inhibiting SEC22A. Disruption of the actin cytoskeleton is also the mechanism by which ML141 and Latrunculin B inhibit SEC22A, as they affect Cdc42 and actin polymerization, respectively, impairing the vesicle transport machinery. Jasplakinolide, on the other hand, stabilizes actin filaments to such an extent that it prevents their necessary dynamics, inhibiting SEC22A by affecting vesicle movement and secretion processes. Finally, Salubrinal and Tunicamycin disrupt protein synthesis regulation and N-linked glycosylation, respectively, both of which are essential for the proper function of proteins that interact with SEC22A, leading to an inhibition of its role in vesicle formation and trafficking.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Salubrinal

405060-95-9sc-202332
sc-202332A
1 mg
5 mg
$34.00
$104.00
87
(2)

Salubrinal selectively inhibits phosphatases targeting the eIF2α subunit, leading to altered protein synthesis regulation. This can inhibit SEC22A by disrupting the balance of proteins necessary for vesicle formation and trafficking.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, which is essential for the proper folding and function of many membrane-bound and secreted proteins. This inhibition can lead to a functional blockade of SEC22A by affecting the protein cargo intended for SEC22A-mediated transport.